| 查看: 449 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题，病人别嘌醇0.1 bid 后尿酸仍在五百多，现在建议苯溴马隆口服，但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了，没有这方面的经验，请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
回复此楼» 猜你喜欢
超级急急急！！！大神们，我想求助关于OGTT的问题
已经有1人回复
-
英国女王大学Dr. Su实验室招2021年博士生
已经有0人回复
-
影像医学与生物医学工程论文润色/翻译怎么收费?
已经有193人回复
-
求助新医学教改标书
已经有0人回复
-
关于凝血功能紊乱定义的高质量英文文献
已经有0人回复
» 本主题相关商家推荐: (我也要在这里推广)
